Pdt Partners, LLC Invitae Corp Transaction History

Pdt Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $252,994 - $1.15 Million	133,155 New	133,155 $328,000
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $765,497 - $1.06 Million	-31,489 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1.23 Million - $1.91 Million	-47,194 Reduced 59.98%	31,489 $1.06 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $2.03 Million - $3.5 Million	61,396 Added 355.16%	78,683 $3.01 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $675,748 - $992,273	17,287 New	17,287 $723,000

Q2 2020 Aug 14, 2020	SELL	$11.71 - $30.29 $269,400 - $696,851	-23,006 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $175,765 - $632,665	23,006 New	23,006 $314,000
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $3.45 Million - $5.22 Million	-198,713 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $780,155 - $1.89 Million	73,254 Added 58.39%	198,713 $4.65 Million
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $1.02 Million - $1.8 Million	-109,641 Reduced 46.64%	125,459 $1.39 Million
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $590,080 - $1.43 Million	78,260 Added 49.9%	235,100 $3.93 Million
Q2 2018 Aug 14, 2018	BUY	$4.87 - $8.42 $33,057 - $57,154	6,788 Added 4.52%	156,840 $1.15 Million
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $170,809 - $366,021	36,420 Added 32.05%	150,052 $704,000
Q4 2017 Feb 14, 2018	BUY	$7.86 - $9.99 $8,111 - $10,309	1,032 Added 0.92%	113,632 $1.03 Million
Q3 2017 Nov 14, 2017	BUY	$8.89 - $10.4 $1 Million - $1.17 Million	112,600	112,600 $1.06 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.